ORAGENICS, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ORAGENICS, INC. (OGEN) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$1.68 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2016-05-16
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-03-31 was -$1.68M.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-12-31 was -$1.61M.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-09-30 was -$1.26M.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-06-30 was -$943.69K.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$5.10M.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$5.56M.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$6.76M.
- ORAGENICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$5.21M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-03-31 | -$1.68M 10-Q · filed 2016-05-16 | -$3.29M derived: sum of 2 quarters · filed 2016-05-16 | -$4.55M derived: sum of 3 quarters · filed 2016-05-16 | -$5.50M derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$2.87M derived: sum of 2 quarters · filed 2016-03-30 | -$3.82M derived: sum of 3 quarters · filed 2016-03-30 | -$5.10M 10-K · filed 2016-03-30 |
| 2015-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$2.21M derived: sum of 2 quarters · filed 2015-11-06 | -$3.50M 10-Q · filed 2015-11-06 | -$4.68M derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-06-30 | -$943.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$2.23M 10-Q · filed 2015-08-07 | -$3.41M derived: sum of 3 quarters · filed 2016-05-16 | -$4.51M derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-03-31 | -$1.29M 10-Q · filed 2016-05-16 | -$2.47M derived: sum of 2 quarters · filed 2016-05-16 | -$3.57M derived: sum of 3 quarters · filed 2016-05-16 | -$5.26M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$2.28M derived: sum of 2 quarters · filed 2016-03-30 | -$3.97M derived: sum of 3 quarters · filed 2016-03-30 | -$5.56M 10-K · filed 2016-03-30 |
| 2014-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$2.79M derived: sum of 2 quarters · filed 2015-11-06 | -$4.38M 10-Q · filed 2015-11-06 | -$5.60M derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$3.28M 10-Q · filed 2015-08-07 | -$4.50M derived: sum of 3 quarters · filed 2015-08-07 | -$6.46M derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | -$1.58M 10-Q · filed 2015-05-08 | -$2.80M derived: sum of 2 quarters · filed 2015-05-08 | -$4.77M derived: sum of 3 quarters · filed 2015-05-08 | -$6.77M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$3.18M derived: sum of 2 quarters · filed 2015-02-27 | -$5.18M derived: sum of 3 quarters · filed 2015-02-27 | -$6.76M 10-K · filed 2015-02-27 |
| 2013-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$3.96M derived: sum of 2 quarters · filed 2014-11-03 | -$5.55M 10-Q · filed 2014-11-03 | |
| 2013-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$3.58M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$1.58M 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | -$5.21M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |